BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

333 related articles for article (PubMed ID: 37638987)

  • 1. [Skin aging-cellular senescence : What is the future?].
    Scharffetter-Kochanek K; Wang Y; Makrantonaki E; Crisan D; Wlaschek M; Geiger H; Maity P
    Dermatologie (Heidelb); 2023 Sep; 74(9):645-656. PubMed ID: 37638987
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Senotherapeutics for mesenchymal stem cell senescence and rejuvenation.
    Wong PF; Dharmani M; Ramasamy TS
    Drug Discov Today; 2023 Jan; 28(1):103424. PubMed ID: 36332835
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Targeting cellular senescence with senotherapeutics: senolytics and senomorphics.
    Zhang L; Pitcher LE; Prahalad V; Niedernhofer LJ; Robbins PD
    FEBS J; 2023 Mar; 290(5):1362-1383. PubMed ID: 35015337
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Senolytics and senomorphics: Natural and synthetic therapeutics in the treatment of aging and chronic diseases.
    Lagoumtzi SM; Chondrogianni N
    Free Radic Biol Med; 2021 Aug; 171():169-190. PubMed ID: 33989756
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Senotherapeutic Drugs: A New Avenue for Skincare?
    Lee BP; Harries LW
    Plast Reconstr Surg; 2021 Dec; 148(6S):21S-26S. PubMed ID: 34847094
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Senolytic Drugs: Reducing Senescent Cell Viability to Extend Health Span.
    Robbins PD; Jurk D; Khosla S; Kirkland JL; LeBrasseur NK; Miller JD; Passos JF; Pignolo RJ; Tchkonia T; Niedernhofer LJ
    Annu Rev Pharmacol Toxicol; 2021 Jan; 61():779-803. PubMed ID: 32997601
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Targeting Cellular Senescence with Senotherapeutics: Development of New Approaches for Skin Care.
    Thompson EL; Pitcher LE; Niedernhofer LJ; Robbins PD
    Plast Reconstr Surg; 2022 Oct; 150():12S-19S. PubMed ID: 36170431
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Looking for the philosopher's stone: Emerging approaches to target the hallmarks of aging in the skin.
    Lemaitre JM
    J Eur Acad Dermatol Venereol; 2024 Jul; 38 Suppl 4():5-14. PubMed ID: 38881451
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The costs and benefits of senotherapeutics for human health.
    Raffaele M; Vinciguerra M
    Lancet Healthy Longev; 2022 Jan; 3(1):e67-e77. PubMed ID: 36098323
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Senolytic and senomorphic interventions to defy senescence-associated mitochondrial dysfunction.
    Nehlin JO
    Adv Protein Chem Struct Biol; 2023; 136():217-247. PubMed ID: 37437979
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Exploring the fuzzy border between senolytics and senomorphics with chemoinformatics and systems pharmacology.
    Olascoaga-Del Angel KS; Gutierrez H; Königsberg M; Pérez-Villanueva J; López-Diazguerrero NE
    Biogerontology; 2022 Aug; 23(4):453-471. PubMed ID: 35781578
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of resibufogenin, a component of toad venom, as a novel senolytic compound in vitro and for potential skin rejuvenation in male mice.
    Takaya K; Asou T; Kishi K
    Biogerontology; 2023 Dec; 24(6):889-900. PubMed ID: 37395866
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Targeting Cellular Senescence for Age-Related Diseases: Path to Clinical Translation.
    Wyles SP; Tchkonia T; Kirkland JL
    Plast Reconstr Surg; 2022 Oct; 150():20S-26S. PubMed ID: 36170432
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The bright and dark side of skin senescence. Could skin rejuvenation anti-senescence interventions become a "bright" new strategy for the prevention of age-related skin pathologies?
    Georgakopoulou EA; Valsamidi C; Veroutis D; Havaki S
    Mech Ageing Dev; 2021 Jan; 193():111409. PubMed ID: 33249190
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Skin senescence: mechanisms and impact on whole-body aging.
    Franco AC; Aveleira C; Cavadas C
    Trends Mol Med; 2022 Feb; 28(2):97-109. PubMed ID: 35012887
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Emergence of Senescent Surface Biomarkers as Senotherapeutic Targets.
    Rossi M; Abdelmohsen K
    Cells; 2021 Jul; 10(7):. PubMed ID: 34359910
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Delay of endothelial cell senescence protects cerebral barrier against age-related dysfunction: role of senolytics and senomorphics.
    Ya J; Kadir RRA; Bayraktutan U
    Tissue Barriers; 2023 Jul; 11(3):2103353. PubMed ID: 35880392
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Promises and challenges of senolytics in skin regeneration, pathology and ageing.
    Pils V; Ring N; Valdivieso K; Lämmermann I; Gruber F; Schosserer M; Grillari J; Ogrodnik M
    Mech Ageing Dev; 2021 Dec; 200():111588. PubMed ID: 34678388
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cellular senescence in bone.
    Farr JN; Khosla S
    Bone; 2019 Apr; 121():121-133. PubMed ID: 30659978
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cellular senescence: a key therapeutic target in aging and diseases.
    Zhang L; Pitcher LE; Yousefzadeh MJ; Niedernhofer LJ; Robbins PD; Zhu Y
    J Clin Invest; 2022 Aug; 132(15):. PubMed ID: 35912854
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.